HEXIM1 and breast cancer: While HEXIM1 is expressed at somewhat higher levels less aggressive slower growing subtypes such as normal-like and luminal breast cancer, HEXIM1 levels are notably decreased in the faster growing subtypes such as HER2 enriched and basal/TNBC breast cancer (Fig. 1a).